[Correspondence] Chlorhexidine and newborn omphalitis and mortality

The following two tabs change content below.
Lancet Global Health
The Lancet Global Health is The Lancet's first gold open-access title and focuses on original research, commentary, correspondence and blogs on topics including maternal and child health, infectious and noncommunicable diseases, mental health, and more. The Editor is Zoë Mullan.

David Osrin and Tim Colbourn (November, 2016)1 uphold a recommendation to restrict use of chlorhexidine to “infants born at home in environments with high neonatal mortality rates” and assert that “Cochrane reviews, a meta-analysis, and these two new trials have not supported an effect after hospital births”. We do not think it is clear how one could come to such a conclusion from the evidence in the cited papers.

Read article here:

[Correspondence] Chlorhexidine and newborn omphalitis and mortality